The global blood plasma products market is forecasted to grow at a CAGR of 6.8% and will reach USD 28.5 Bn in 2023 from USD 20.5 Bn in 2018. The increasing demand of immunoglobulin for the treatment of immunodeficiency drives market growth.

Blood Plasma Products Market Overview:

The blood plasma products market is segmented based on product types like immunoglobulin, albumin, hyperimmune globulin, coagulation factor VIII, coagulation factor IX, and other plasma products. The market is also segmented based on end users such as hospitals, clinics, and other end users. Rise in technology at plasma collection centers to collect plasma and record patient history, and use of dried plasma that reduced cold chain requirements are the major trends in the market that may boost the market growth.

Get Free Sample PDF Copy of Latest Research on Blood Plasma Products Market 2021 Before the purchase @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=130606&RequestType=Sample&utm_source=Arshad&utm_medium=globalbankingandfinance

Companies covered

• CSL Behring
• Shire Plc
• Grifols S.A.
• Octapharma AG
• ADMA Biologics
• Kedrion Biopharma

Segmentation Based On Product Types

Based on product types, immunoglobulin market has the highest market share (approximately 47%) because of the growing incidence of immunological diseases coupled with the rise in the geriatric population. The market share of albumin was 15.6% in 2018 which is driven by the rise in adoption of albumin in developing countries and an increase in awareness of recombinant albumin but post-operative risks associated with albumin-based therapy may hamper the market growth. Albumin market share is followed by hyperimmune globulin, coagulation factor VIII, and coagulation factor IX in 2018.

Segmentation based on End Users

On the basis of end users, the hospital segment dominated the market with a market share of ~82% in 2018. This is due to the increase in the number of hospitals in developing countries and the rise in awareness of diseases like hemophilia. It is followed by clinics with a market share of 14.1% in 2018. The clinics market is driven by the growing number of clinics, increase in awareness among patients regarding plasma products and rise in the number of patients with blood and immunological disorders. Other end users that include research institutes, blood transfusion centers, and academic institutes was having the least market share in 2018.

Chapter 1: Executive summary

1.1. Market scope and segmentation

1.2. Key questions answered in the study

1.3. Executive summary

Chapter 2: Introduction

2.1. Market definitions

2.2. Global market trends

2.3. Global drivers

2.4. Global challenges

2.5. Revenue based on product types – 2018 (USD Bn)

2.6. Revenue based on end users – 2018 (USD Bn)

2.7. Value chain of blood plasma products market

Chapter 3: Global Blood Plasma Products Market Overview

3.1. Market overview

3.1.a. Global historical market revenue – (2015-2017) (USD Bn)

3.1.b. Global forecast market revenue – (2018-2023) (USD Bn)

3.1.c. Geography-wise market revenue – (2018, 2023) (USD Bn)

Chapter 4: Global Blood Plasma Products Market – Based on Product Types

4.1. Global Immunoglobulin market

4.1.a. Market Overview

4.1.b. Regional Revenue Contribution

4.2. Global Albumin market

4.2.a. Market Overview

4.2.b. Regional Revenue Contribution

4.3. Global Hyperimmune Globulin market

4.3.a. Market Overview

4.3.b. Regional Revenue Contribution

4.4. Global Coagulation Factor VIII market

4.4.a. Market Overview

4.4.b. Regional Revenue Contribution

4.5. Global Coagulation Factor IX market

4.5.a. Market Overview

4.5.b. Regional Revenue Contribution

4.6. Global Other Plasma Products market

4.5.a. Market Overview

4.5.b. Regional Revenue Contribution

Request for Methodology of this report: https://brandessenceresearch.biz/Request/Sample?ResearchPostId=130606&RequestType=Methodology&utm_source=Arshad&utm_medium=globalbankingandfinance

Chapter 5: Global Blood Plasma Products Market – Based on End Users

5.1. Global Hospitals market

4.1.a. Market Overview

4.1.b. Regional Revenue Contribution

5.2. Global Clinics market

4.2.a. Market Overview

4.2.b. Regional Revenue Contribution

5.3. Global Other End Users market

4.3.a. Market Overview

4.3.b. Regional Revenue Contribution

Chapter 6: Global Blood Plasma Products Market – Based on Regions

6.1. North America market

6.1.a. Market Overview by Product Types

6.1.b. Market Overview by End Users

6.2. Europe market

6.2.a. Market Overview by Product Types

6.2.b. Market Overview by End Users

6.3. Asia-Pacific market

6.3.a. Market Overview by Product Types

6.3.b. Market Overview by End Users

6.4. Latin America market

6.4.a. Market Overview by Product Types

6.4.b. Market Overview by End Users

6.5. The Middle-East and Africa market

6.5.a. Market Overview by Product Types

6.5.b. Market Overview by End Users

Regional insights

North America is leading the blood plasma products market and occupied approximately 44.2% of the market in 2018. This is due to the rising incidence of haemophilia, and rapid approval by the FDA for the plasma products. Europe is likely to expand over the forecast period of 2018-2023, by exhibiting a CAGR of 6.6%. This is due to easy access to high-quality plasma through the contributions of qualified donors. Europe is followed by the Asia pacific with a market share of 19.3% in 2018.

India and China are the major contributors of plasma products market in the Asia-Pacific region due to a large number of immunodeficient patients to get treated in hospitals and clinics. The Latin America and the Middle-East and Africa markets though, still at nascent stages, will also experience high growth because of the growing prevalence of blood disorders.

Global Blood Plasma Products Markets: Regional Analysis

• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
• South America (Brazil etc.)
• Middle East and Africa (Egypt and GCC Countries)

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

AboutBrandessence Market Research Inc.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact Us:

Alan Ruffalo

Corporate Sales: +44-20380741

Email: [email protected]

Related Reports:

Global Direct-To-Consumer Genetic Testing market size is expected to gain market growth with a CAGR of 12.8% in the forecast period of 2021 to 2027

Global Anti-Corrosion Coatings market size is expected to gain market growth in the forecast period of 2021 to 2027, with a CAGR of 5% in the forecast period of 2021 to 2027